Skip Navigation

Link to  the National Institutes of Health NIDA NEWS NIDA News RSS Feed
The Science of Drug Abuse and Addiction from the National Institute on Drug Abuse Keep Your Body Healthy
Go to the Home pageGo to the About Nida pageGo to the News pageGo to the Meetings & Events pageGo to the Funding pageGo to the Publications page
PhysiciansResearchersParents/TeachersStudents/Young AdultsEn Español Drugs of Abuse & Related Topics

NIDA Home > Funding    

Past Requests for Applications (RFAs)

 

Return to Current Funding page

FY 2007 RFA's

  • RFA-DA-07-013 Joint NIDA-NIJ Initiative for Research on Retail Drug Markets (R21)
    [Receipt Date: February 23, 2007]
  • RFA-DA-07-012 The Genes, Environment, and Development Initiative (U01)
    [Receipt Date: March 15, 2007]
  • RFA-DA-07-011 Extinction and Pharmacotherapies for Drug Addiction (R03)
    [Receipt Date: February 26, 2007]
  • RFA-DA-07-010 Extinction and Pharmacotherapies for Drug Addiction (R01)
    [Receipt Date: February 26, 2007]
  • RFA-DA-07-008 Exploratory/Developmental Centers for Translational Research on the Clinical Neurobiology of Drug Addiction (P20)
    [Receipt Date: February 23, 2007]
  • RFA-DA-07-007 Brain Imaging Drug Use Prevention Messages (R21)
    [Receipt Date: March 15, 2007]
  • RFA-DA-07-006 Design, Synthesis, and Preclinical Testing of Potential Treatment Agents for Drug Addiction (R01)
    [Receipt Date: January 26, 2007]
  • RFA-DA-07-005 Field-Deployable Tools for Quantifying Exposures to Psychosocial Stress and to Addictive Substances for Studies of Health and Disease (U01)
    [Receipt Date: December 22, 2006]
  • RFA-DA-07-004 Development of Immunotherapeutic Products for the Treatment of Methamphetamine Addiction (U01)
    [Receipt Date: January 11, 2007]
  • RFA-DA-07-003 Mechanisms of Drug Abuse Interactions with HIV Neuropathogenesis (R21)
    [Receipt Date: March 21, 2007]
  • RFA-DA-07-002 Mechanisms of Drug Abuse Interactions with HIV Neuropathogenesis (R01)
    [Receipt Date: March 21, 2007]
  • RFA-DA-07-001 Announcement of a Limited Competition of THE NATIONAL DRUG ABUSE TREATMENT CLINICAL TRIALS NETWORK (U10)
    [Receipt Date: November 28, 2006]

Other RFAs in which NIDA is Participating

  • Technology Development in Epigenetics
    RFA-RM-07-011 (R01), RFA-RM-07-012 (R21) - [Receipt Date: February 14, 2008]
  • Discovery of Novel Epigenetic Marks in Mammalian Cells
    RFA-RM-07-015 (R01), RFA-RM-07-016 (R21) - [Receipt Date: February 14, 2008]
  • Reference Epigenome Mapping Centers (U01)
    RFA-RM-07-013 (U01) - [Receipt Date: March 07, 2008]
  • RFA-AI-07-031 U.S.-India Bilateral Collaborative Research Partnerships (CRP) on the Prevention of HIV/AIDS (R21)
    [Receipt Date: October 18, 2007]
  • RFA-RR-07-005 Clinical Research Education and Career Development (CRECD) in Minority Institutions (R25)
    [Receipt Date: October 24, 2007]
  • RFA-HG-07-012 Genome-wide Association Studies in the Genes, Environment, and Health Initiative - Study Investigators (U01)
    [Receipt Date: October 18, 2007]
  • RFA-AI-07-004 Women's Interagency HIV Study (WIHS) IV, Limited Competition (U01)
    [Receipt Date: March 13, 2007]
  • RFA-RM-07-006 Limited Competition for Supplements to CTSAs to Plan for Pilot Projects to Apply the National Clinical Research Associates Model in Their Community Engagement Activities (UL1)
    [Receipt Date: January 22, 2007]
  • RFA-RM-07-002 Institutional Clinical and Translational Science Award (U54)
    National Institutes of Health
    [Receipt Date: January 17, 2007]

FY 2006 RFAs

  • RFA-DA-06-011 Training in Neuroimaging: Integrating First Principles and Applications (T90) (NIH Blueprint for Neuroscience Research)
    [Receipt Date: March 13, 2006]
  • RFA-DA-06-010 Training in Computational Neuroscience: From Biology to Model and Back Again (T90) (NIH Blueprint for Neuroscience Research)
    [Receipt Date: March 13, 2006]
  • RFA-MH-06-006 Course Development in the Neurobiology of Disease
    [Receipt Date: February 16, 2006]
  • RFA-DA-06-009 Development and Improvement of Inbred ES Cell Lines for Use in Generation of Mouse Mutants
    [Receipt Date: November 22, 2005]
  • RFA-DA-06-008 Training in Translational Research in Neurobiology of Disease (T32)
    [Receipt Date: February 22, 2006]
  • RFA-DA-06-007 Epigenetics of Neurobiology and Addiction
    [Receipt Date: January 23, 2006]
  • RFA-DA-06-006 Developmental Centers for Translational Research on the Clinical Neurobiology of Drug Addiction (P20)
    [Receipt Date: February 23, 2006]
  • RFA-DA-06-005 Prescription Opioid Use and Abuse in the Treatment of Pain (R01, R03, R21, R25)
    [Receipt Date: February 23, 2006]
  • RFA-DA-06-004 Social Neuroscience
    [Receipt Date: February 23, 2006]
  • RFA-DA-06-002 Pilot Clinical Trials of Pharmacotherapies for Substance Related Disorders
    [Receipt Date: January 24, 2006]
  • RFA-DA-06-001 Enhancing Practice Improvement in Community-Based Care for Prevention and Treatment of Drug Abuse or Co-occurring Drug Abuse and Mental Disorders
    [Receipt Date: December 19, 2005]

FY 2005 RFAs

  • RFA-DA-05-009 Strategic Program for Innovative Research on Drug Addiction Pharmacotherapy (SPIRDAP)
    [Receipt Date: April 18, 2005]
  • RFA-DA-05-008 HIV and Drug Abuse Interventions among Pregnant Women in Drug Abuse Treatment
    [Receipt Date: March 21, 2005]
  • RFA-DA-05-007 Consequences of Drug Abuse and Alcohol Exposure on Brain and Behavioral Development
    [Receipt Date: April 18, 2005]
  • RFA-DA-05-006 Neurobiology of Behavioral Treatment: Recovery of Brain Structure and Function
    [Receipt Date: March 21, 2005]
  • RFA-DA-05-005 Secondary Analysis of the NESARC and NSPY Datasets
    [Receipt Date: March 21, 2005]
  • RFA-DA-05-004 Lapse or Relapse to Drug Abuse and Other Chronic Conditions
    [Letter of Intent Date: December 27, 2004] [Receipt Date: January 25, 2005]
  • NSF-04-607 Interagency Opportunities in Multi-Scale Modeling in Biomedical, Biological, and Behavioral Systems
    [Letter of Intent Date: September 22, 2004] [Receipt Date: November 9, 2004]
  • RFA-DA-05-001 The National Drug Abuse Treatment Clinical Trials Network
    [Receipt Date: October 14, 2004]

Return to Current Funding page


drugabuse.gov graphic


NIDA Home | Site Map | Search | FAQs | Accessibility | Privacy | FOIA (NIH) | Employment | Print Version


National Institutes of Health logo_Department of Health and Human Services Logo The National Institute on Drug Abuse (NIDA) is part of the National Institutes of Health (NIH) , a component of the U.S. Department of Health and Human Services. Questions? See our Contact Information. Last updated on Tuesday, May 20, 2008. The U.S. government's official web portal